Post Author: Muhamad Aly Rifai, MD
Muhamad Aly Rifai is a practicing internist and psychiatrist in the Greater Lehigh Valley, Pennsylvania. He is the CEO, chief psychiatrist and internist of Blue Mountain Psychiatry. He holds the Lehigh Valley Endowed Chair of Addiction Medicine. Dr. Rifai is board-certified in internal medicine, psychiatry, addiction medicine, and psychosomatic medicine. He is a fellow of the American College of Physicians, the Academy of Psychosomatic Medicine, and the American Psychiatric Association. He is the former president of the Lehigh Valley Psychiatric Society.
He can be reached on LinkedIn, Facebook, X @muhamadalyrifai, YouTube, and his website. You can also read his Wikipedia entry and publications.
Muhamad Aly Rifai is a practicing internist and psychiatrist in the Greater Lehigh Valley, Pennsylvania. He is the CEO, chief psychiatrist and internist of Blue Mountain Psychiatry. He holds the Lehigh Valley Endowed Chair of Addiction Medicine. Dr. Rifai is board-certified in internal medicine, psychiatry, addiction medicine, and psychosomatic medicine. He is a fellow of the American College of Physicians, the Academy of Psychosomatic Medicine, and the American Psychiatric Association. He is the former president of the Lehigh Valley Psychiatric Society.
He can be reached on LinkedIn, Facebook, X @muhamadalyrifai, YouTube, and his website. You can also read his Wikipedia entry and publications.
Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder that impairs focus, attention, and behavioral control. ADHD hinders and compromises major life activities. Initially considered exclusively a disorder afflicting children and adolescents, it is now widely accepted that ADHD continues into adulthood, impacting the lives of those plagued by this impairment and disability. Furthermore, ADHD symptoms may fluctuate over the lifespan of an individual who struggles with a myriad of …
Read more…
As health care predictive algorithms, including the Prescription Drug Monitoring Programs (PDMP), expand their reach beyond traditional enforcement of health care regulations, the concept of a social credit score has emerged as a powerful but controversial tool. Like predictive policing, social credit scores use an individual’s behaviors, online activity, and social interactions to assess their perceived trustworthiness and risk to society and are used as fodder for the prosecution of …
Read more…
Artificial intelligence (AI) is a virtual construct that uses algorithms, data, and computational power to simulate human intelligence in machines. Physicians and health care professionals often imagine AI as a futuristic, benevolent, childlike humanoid with the unique ability to love, as depicted in the 2001 Steven Spielberg movie A.I. Artificial Intelligence. However, the United States Department of Justice (DOJ) disagrees. In 2022, the DOJ announced the widespread deployment of AI, …
Read more…
As the crescendo of a seven-year alleged health care fraud investigation, the trial in the Eastern District of Pennsylvania opened in late April 2024. The trial is one of less than two percent of the federal criminal cases filed that ultimately end up in a jury trial. This flawed prosecution targeted an exemplary physician who, like the majority of physicians in the United States, has spent most of their lives …
Read more…